Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/22/2023 | Certara, Inc. | | Purchase | Common Stock | 4.8k | $15.80 | $76k | | 08/21/2023 |
08/21/2023 | Certara, Inc. | | Purchase | Common Stock | 193 | $16.10 | $3.1k | | 08/21/2023 |
05/23/2023 | Certara, Inc. | | Exercise | Restricted Stock Units | 9.4k | $0.00 | $0 | | 05/23/2023 |
05/23/2023 | Certara, Inc. | | Grant | Restricted Stock Units | 8.7k | $0.00 | $0 | | 05/23/2023 |
05/02/2023 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 22k | $10.95 | $241.4k | | 05/02/2023 |
05/02/2023 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.1k | $0.00 | $0 | | 05/02/2023 |
07/13/2022 | Certara, Inc. | | Grant | Restricted Stock Units | 9.4k | $0.00 | $0 | | 07/13/2022 |
04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.9k | $0.00 | $0 | | 04/26/2022 |
04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 28k | $10.15 | $284.2k | | 04/26/2022 |
04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $20.35 | $122.1k | | 04/27/2021 |
04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.8k | $0.00 | $0 | | 04/27/2021 |
04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $30.14 | $180.8k | | 04/28/2020 |
04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6.6k | $0.00 | $0 | | 04/28/2020 |
04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $23.85 | $143.1k | | 04/30/2019 |
04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.4k | $0.00 | $0 | | 04/30/2019 |
05/24/2018 | MAGELLAN HEALTH INC | MGLN | Grant | Ordinary Common Stock, $0.01 par value | 1.7k | $0.00 | $0 | | 05/24/2018 |
05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.2k | $0.00 | $0 | | 05/01/2018 |
05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $24.43 | $146.6k | | 05/01/2018 |
05/17/2017 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6k | $0.00 | $0 | | 05/17/2017 |
12/08/2016 | MAGELLAN HEALTH INC | MGLN | Sale | Ordinary Common Stock, $0.01 par value | 2.4k | $75.00 | $182.5k | | 12/08/2016 |
05/03/2016 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6k | $0.00 | $0 | | 05/03/2016 |
04/22/2015 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6k | $0.00 | $0 | | 04/22/2015 |
06/03/2014 | Theravance Biopharma, Inc. | TBPH | Grant | Stock Option (Right to Buy) | 12k | $23.51 | $282.1k | | 06/03/2014 |
05/21/2014 | MAGELLAN HEALTH INC | MGLN | Grant | Ordinary Common Stock, $0.01 par value | 2.1k | $0.00 | $0 | | 05/21/2014 |
05/22/2013 | MAGELLAN HEALTH INC | MGLN | Grant | | 2.4k | $0.00 | $0 | | 05/22/2013 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Common Stock | 249.9k | $0.00 | $0 | | 08/04/2010 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Stock Option (right to buy) | 55k | $8.45 | $464.8k | | 08/04/2010 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Stock Option (right to buy) | 48.3k | $32.55 | $1.6M | | 08/04/2010 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Stock Option (right to buy) | 200k | $15.96 | $3.2M | | 08/04/2010 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Stock Option (right to buy) | 45k | $25.06 | $1.1M | | 08/04/2010 |
08/04/2010 | INVENTIV HEALTH INC | VTIV | Disposition | Stock Option (right to buy) | 180k | $26.77 | $4.8M | | 08/04/2010 |
06/15/2010 | INVENTIV HEALTH INC | VTIV | Purchase | Common Stock | 22.8k | $25.15 | $573.6k | | 06/15/2010 |
12/15/2009 | NEUROGEN CORP | NRGN | Grant | Stock Options (Right to Buy) | 2.5k | $0.17 | $432 | | 12/15/2009 |